Study on antifibrotic effects of curcumin in rat hepatic stellate cells

Phytotherapy Research

Volumn 23, Issue 7, 2009, Pages 927-932

  Lin, Yun Lian ^a   Lin, Chia Yu ^b   Chi, N Wen ^b,c   Huang, Yi Tsau ^b  

^a NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

smooth muscle actin transforming growth factor 1; Apoptosis; Curcumin; Hepatic fibrosis; Hepatic stellate cells

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANTIFIBROTIC AGENT; COLLAGEN; CURCUMIN; CYTOCHROME C; HOE 33342; PROPIDIUM IODIDE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; LIVER CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; STELLATE CELL;

ACTINS; ANIMALS; APOPTOSIS; CELL LINE; COLLAGEN; CURCUMIN; CYTOCHROMES C; HEPATIC STELLATE CELLS; LIVER CIRRHOSIS; RATS; TRANSFORMING GROWTH FACTOR BETA1;

CURCUMA LONGA; RATTUS;

EID: 67650152203     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2764     Document Type: Article

References (26)

1. Bataller R, Brenner DA. 2005. Liver fibrosis. J Clin Invest 115: 209-218.
2. Chen A, Zheng S. 2007. Curcumin inhibits connective tissue growth factor expression in activated hepatic stellate cells in vitro by blocking NF-κB and ERK signaling. Br J Pharmacol 153: 557-567.
3. Elsharkawy AM, Oakley F, Mann DA. 2005. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis 10: 927-939. (Pubitemid 41285572)
4. Fadeel B, Orrenius S. 2005. Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease. J Int Med 258: 479-517. (Pubitemid 41705391)
5. Friedman SL. 2008a. Mechanisms of hepatic fibrogenesis. Gastroenterology 134: 1655-1669.
6. Friedman SL. 2008b. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 88: 125-172.
7. 4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Mol Pharmacol 73: 399-409.
8. Gebhardt R. 2002. Oxidative stress, plant-derived antioxidants and liver fibrosis. Planta Med 68: 289-296. (Pubitemid 34494036)
9. Goel A, Kunnumakkara AB, Aggarwal BB. 2008. Curcumin as 'curecumin': from kitchen to clinic. Biochem Pharmacol 75: 787-809.
10. Henderson NC, Iredale JP. 2007. Liver fibrosis: cellular mechanisms of progression and resolution. Clin Sci 112: 265-280. (Pubitemid 46392114)
11. Hsu Y-C, Chiu Y-T, Cheng C-C, Wu C-F, Lin Y-L, Huang Y-T. 2007. Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis. J Gastroenterol Hepatol 22: 99-111. (Pubitemid 44953424)
12. Issa R, Williams E, Trim N, Kendall T, Arthur MJ, Reichen J, Benyon RC, Iredale JP. 2001. Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors. Gut 48: 548-557. (Pubitemid 32234801)
13. Kweon YO, Paik YH, Schnabl B, Qian T, Lemasters JJ, Brenner DA. 2003. Gliotoxin-mediated apoptosis of activated human hepatic stellate cells. J Hepatol 39: 38-46. (Pubitemid 36724106)
14. Lee T-F, Lin Y-L, Huang Y-T. 2007. Anti-proliferative effects of phthalides from Ligusticum chuanxiong in hepatic stellate cells. Planta Med 73: 527-534. (Pubitemid 46984839)
15. Lee YJ, Shukla SD. 2005. Pro- and anti-apoptotic roles of c-Jun N-terminal kinase (JNK) in ethanol and acetaldehyde exposed rat hepatocytes. Eur J Pharmacol 508: 31-45. (Pubitemid 40169900)
16. Lin J, Chen A. 2008. Activation of peroxisome proliferator-activated receptor-γ by curcumin blocks the signaling pathways for PDGF and EGF in hepatic stellate cells. Lab Invest 88: 529-540. (Pubitemid 351581455)
17. Lin Y-L, Lee T-F, Huang Y-T. 2006a. Inhibitory effects of Ligusticum chuanxiong on the proliferation of rat hepatic stellate cells. J Gastroenterol Hepatol 21: 1257-1265. (Pubitemid 44034337)
18. Lin Y-L, Wu C-H, Luo M-H, Huang Y-J, Wang C-N, Shiao M-S, Huang Y-T. 2006b. In vitro protective effects of salvianolic acid B on primary hepatocytes and hepatic stellate cells. J Ethnopharmacol 105: 215-222.
19. Malhi H, Gores GJ. 2008. Cellular and molecular mechanisms of liver injury. Gastroenterology 134: 1641-1654. (Pubitemid 351615416)
20. Nanji AA, Jokelainen K, Tipoe GL, Rahemtulla A, Thomas P, Dannenberg AJ. 2003. Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-κB-dependent genes. Am J Physiol Gastrointest Liver Physiol 284: G321-G327. (Pubitemid 36120138)
21. Schuppan D, Jia JD, Brinkhaus B, Hahn EG. 1999. Herbal products for liver diseases: a therapeutic challenge for the new millennium. Hepatology 30: 1099-1104. (Pubitemid 29458302)
22. Shimizu I, Ma Y-R, Mizobuchi Y, Liu F, Miura T, Nakai Y, Yasuda M, Shiba M, Horie T, Amagaya S, Kawada N, Hori H, Ito S. 1999. Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats. Hepatology 29: 149-160. (Pubitemid 29023997)
23. Strimpakos AS, Sharma RA. 2008. Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid Redox Signal 10: 511-546.
24. Vogel S, Piantedosi R, Frnak J, Lalazar A, Rockey DC, Friedman SL, Blaner WS. 2000. An immortalized rat liver stellate cell (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J Lipid Res 41: 882-893. (Pubitemid 30434319)
25. Wright MC, Issa R, Smart DE, Trim N, Murray GI, Primrose JN, Arthur MJ, Iredale JP, Mann DA. 2001. Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. Gastroenterology 121: 685-698. (Pubitemid 32822584)
26. Xu J, Fu Y, Chen A. 2003. Activation of peroxisome proliferatoractivated receptor-γ contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. Am J Physiol Gastrointest Liver Physiol 285: G20-G30. (Pubitemid 36736384)